X0306 4 2017-04-19 0 0001628908 Evolent Health, Inc. EVH 0001643086 McGrane Nicholas C/O EVOLENT HEALTH, INC. 800 N. GLEBE ROAD, SUITE 500 ARLINGTON VA 22203 0 1 0 0 Chief Financial Officer Class A Common Stock 2017-04-19 4 M 0 1667 3.84 A 132047 D Class A Common Stock 2017-04-19 4 S 0 1667 22.52 D 130380 D Class A Common Stock Option (right to buy) 3.84 2017-04-19 4 M 0 1667 0 D 2024-10-22 Class A Common Stock 1667 272127 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. The shares were sold in multiple transactions at prices ranging from $22.50-22.525, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The Class A Common Stock Options exercised vested on November 1, 2015. One fourth of the Class A Common Stock Options granted to the reporting person on October 22, 2014 vested on November 1, 2015; the balance vested or vests at a rate of 6.25% as of the end of each three-month period immediately thereafter during the period beginning on October 23, 2015, the day following the first anniversary of the grant date. /s/ Jonathan Weinberg, Attorney-in-fact 2017-04-21